Physician profile
Rito Lopez
NPI 1124667779
$3,172.84
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,081 · 2022: $1,092.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $520.34 | 2021-2022 | |
| Lilly USA, LLC | $300.86 | 2021-2022 | |
| Novo Nordisk INC | $248.98 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $232.21 | 2021-2022 | |
| Abbvie INC. | $223.46 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $196.65 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $194.25 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $137.10 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.87 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $126.65 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $118.75 | 2021 | |
| Biogen, INC. | $80.83 | 2021 | |
| Arbor Pharmaceuticals, INC. | $75.00 | 2021-2022 | |
| Esperion Therapeutics, INC. | $67.17 | 2021 | |
| Glaxosmithkline, LLC. | $56.97 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $56.83 | 2021 | |
| Electromed, INC. | $55.95 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $47.27 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.99 | 2021 | |
| Scilex Pharmaceuticals INC. | $41.98 | 2021-2022 | |
| Pfizer INC. | $41.25 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $35.65 | 2021-2022 | |
| Astellas Pharma US INC | $33.30 | 2021 | |
| Alexion Pharmaceuticals, INC. | $27.22 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $20.09 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $18.97 | 2022 | |
| Daiichi Sankyo INC. | $18.19 | 2021 | |
| Nevro Corp. | $18.06 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rito Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.